Benzodiazepine deaths increased from April-June 2019 to April-June 2020, with larger increase for illicit benzodiazepine deaths
Odds increased for developing alcohol use disorders, cannabis use disorders, other drug use disorders
Odds increased for developing alcohol use disorders, cannabis use disorders, other drug use disorders
However, survivors had more problems with mobility, pain or discomfort, anxiety or depression at one year than controls
Findings show noninferior outcomes at three months versus cognitive behavioral therapy
Findings based on a systematic literature review of studies reporting the use of ketamine, esketamine for treatment-resistant depression
Vaccine hesitancy highest among Black and Hispanic or Latino health care workers; concerns include side effects, newness of vaccine